Vanda Escalates Vendetta Against FDA, Blasts ‘Bureaucrats’ For Delaying Stomach Drug

The tradipitant saga stretches back to September 2024, when the FDA declined to approve Vanda’s drug in gastroparesis, a stomach condition characterized by delayed gastric emptying.